Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Report

Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674

Steve Lancel, Jingmei Zhang, Alicia Evangelista, Mario P. Trucillo, XiaoYong Tong, Deborah A. Siwik, Richard A. Cohen, Wilson S. Colucci
Download PDF
https://doi.org/10.1161/CIRCRESAHA.108.188441
Circulation Research. 2009;104:720-723
Originally published March 26, 2009
Steve Lancel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingmei Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alicia Evangelista
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario P. Trucillo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XiaoYong Tong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah A. Siwik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Cohen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilson S. Colucci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

This article has a correction. Please see:

  • Correction - May 25, 2012
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics

Jump to

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Abstract

Nitroxyl (HNO) exerts inotropic and lusitropic effects in myocardium, in part via activation of SERCA (sarcoplasmic reticulum calcium ATPase). To elucidate the molecular mechanism, adult rat ventricular myocytes were exposed to HNO derived from Angeli’s salt. HNO increased the maximal rate of thapsigargin-sensitive Ca2+ uptake mediated by SERCA in sarcoplasmic vesicles and caused reversible oxidative modification of SERCA thiols. HNO increased the S-glutathiolation of SERCA, and adenoviral overexpression of glutaredoxin-1 prevented both the HNO-stimulated oxidative modification of SERCA and its activation, as did overexpression of a mutated SERCA in which cysteine 674 was replaced with serine. Thus, HNO increases the maximal activation of SERCA via S-glutathiolation at cysteine 674.

  • sarcoplasmic reticulum ATPase
  • SERCA
  • nitroxyl
  • glutathiolation
  • cardiac myocytes

Nitroxyl (HNO), the 1-electron reduced and protonated form of nitric oxide (NO), exerts a bioactivity profile that differs markedly from NO1,2⇓ and other reactive nitrogen species such as peroxynitrite.3 In the cardiovascular system, HNO derived from Angeli’s salt (AS) exerts inotropic and lusitropic effects in the myocardium4 and causes relaxation of vascular smooth muscle.5,6⇓ These observations have raised the possibility that HNO is involved in cardiovascular regulation and/or may have therapeutic potential.

In cardiac myocytes, HNO increases calcium cycling in association with increasing the activities of SERCA (sarcoplasmic reticulum ATPase) and the calcium release channel (CRC).1 In vascular smooth muscle cells SERCA activity can be increased by NO-induced S-glutathiolation.7 Accordingly, we hypothesized that in cardiac myocytes HNO can activate SERCA via S-glutathiolation.

Materials and Methods

In all experiments, adult rat ventricular myocytes (ARVMs)8 were exposed for 15 minutes to 500 ?mol/L AS dissolved in 10 mmol/L NaOH. Detailed methods are provided in the online supplement at http://circres.ahajournals.org.

Results and Discussion

HNO Activation of SERCA Involves Reversible, Oxidative Thiol Modification

AS increased myocyte shortening (?2-fold) and accelerated relaxation (Figure I in the online data supplement), confirming the findings of Tocchetti et al.1 In the absence of dithiothreitol (DTT), AS (500 ?mol/L; 15 minutes) increased maximal SERCA activity ?3-fold (Figure 1A). In the presence of DTT (2 mmol/L), HNO had no effect on SERCA activity (+3±11%; P=NS; n=3). Iodoacetamide binds preferentially to reactive thiolate anions at pH 6.59 and to cysteine 674 of SERCA, in particular.10,11⇓ Oxidative modification of SERCA thiols was assessed using biotinylated iodoacetamide (BIAM).7,9⇓ HNO (500 ?mol/L; 15 minutes) decreased BIAM binding to SERCA thiols by 27±3% (Figure 1B; P<0.0001; n=14). In some experiments, ARVMs exposed to AS for 15 minutes were washed for an additional 15 minutes. After washout, the amount of BIAM-labeled SERCA was similar in HNO-treated and control cells (Figure 1C and 1D; P<0.01; n=4), indicating that the HNO-mediated modification is reversible. This finding is consistent with our observation that HNO-stimulated SERCA activation is prevented by DTT and the prior observation by Tocchetti et al1 that the effects of HNO on cardiac myocyte function are reversed by DTT or removal of AS from the perfusion buffer.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. HNO activation of SERCA involves reversible thiol modification. A, In ARVMs, AS (500 ?mol/L, 15 minutes) increased maximal SERCA activity (*P<0.001 vs vehicle control; n=4), measured as the initial rate of thapsigargin-sensitive 45Ca2+ uptake in a postnuclear supernatant fraction. This effect was prevented by DTT (online data supplement). B, AS (500 ?mol/L, 15 minutes) decreased the fraction of BIAM-labeled SERCA (†P<0.0001 vs vehicle control; n=14). C, This effect was reversed by subsequent washing (15 minutes) to remove AS (†P<0.01 vs vehicle control; n=4). D, Representative Western blot showing effects of AS and washout on BIAM-labeled and total SERCA. Data in B and D were normalized to the means of the control values.

Editor's Note: The authors have identified errors in this Figure. A revised figure and explanation can be found in the accompanying Correction Notice.

HNO Activates SERCA via S-Glutathiolation

We have shown that oxidative activation of SERCA7 and p21 Ras12,13⇓ is mediated via the formation of mixed disulfides leading to protein S-glutathiolation. S-Glutathiolation of SERCA was assessed by immunoprecipitation of SERCA followed by immunoblotting with an antibody directed against glutathione.13 HNO caused an 18±4% increase in SERCA S-glutathiolation (P<0.05; n=5), which was abolished by DTT (Figure 2A and 2B). To further examine the role of S-glutathiolation, glutaredoxin-1 (GRX) was overexpressed (?10-fold) via adenoviral infection (supplemental Figure II). In control ARVMs expressing ?-galactosidase, HNO decreased BIAM-labeled SERCA by 43±13% (P<0.05; n=4), whereas in GRX-expressing cells, the effect of HNO was abolished (Figure 2C and 2D; P=NS; n=4). In ?-galactosidase expressing cells, AS increased maximal SERCA activity by 42±5%, whereas in GRX-expressing cells HNO had no effect (Figure 2E; P=NS, n=4). Together with the demonstration that HNO increases S-glutathiolation of SERCA, the ability of GRX to prevent SERCA thiol oxidative modification and SERCA activation supports the conclusion that the major HNO-induced oxidative modification of SERCA is S-glutathiolation and is consistent with our prior demonstration that SERCA S-glutathiolation stimulates maximal enzyme activity in vascular smooth muscle cells and heart or purified SERCA in phospholipid vesicles.7

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. HNO activates SERCA via S-glutathiolation. A, AS (500 ?mol/L, 15 minutes) increases S-glutathiolation of SERCA (*P<0.05 vs control; n=5). B, Representative Western blot showing increased S-glutathiolation by addition of AS, and reversal by the addition of DTT (10 mmol/L) before BIAM labeling. C, GRX prevents the decrease in BIAM labeling caused by AS (*P<0.05 vs control; n=4). D, Representative Western blot. E, GRX prevents the AS-stimulated increase in maximal SERCA activity (*P<0.05 vs control; n=4). Data in A and C were normalized to the means of the control values.

Cysteine 674 Modulates HNO-Stimulated SERCA Activity

Of the 14 surface thiols of SERCA, iodoacetamide preferentially binds to cysteine 674.10,11⇓ To test the role of cysteine 674 in mediating the effect of HNO in ARVMs, we overexpressed (?5-fold; supplemental Figure III) wild-type SERCA or a mutated SERCA (C674S) in which cysteine 674 was replaced by serine. Of note, the amount of accessible SERCA thiols labeled by BIAM was reduced by 52±7% in cells expressing C674S (Figure 3A and 3B; P<0.01, n=3), indicating that cysteine 674 accounts for approximately half of the labeling of wild-type SERCA. In cells expressing wild-type SERCA, HNO decreased BIAM labeling by 65±8% (P<0.01, n=3) but, in contrast, caused no further decrease in the BIAM labeling of SERCA in cells expressing the C674S mutant (Figure 3A and 3B). In cells expressing wild-type SERCA, HNO stimulated SERCA activity by 59±12% but caused no stimulation in cells expressing the C674S mutant (Figure 3C). Likewise, HNO had no effect on myocyte contraction or relaxation in cells expressing the C674S mutant (supplemental Figure I). Thus, the cysteine 674 thiol is the molecular target that accounts for the HNO-mediated oxidative modification and activation of SERCA. Although it is possible that HNO causes oxidative modifications of other SERCA reactive cysteines14 and/or other amino acids, our data indicate that in cardiac myocytes S-glutathiolation of cysteine 674 is the most abundantly modified thiol and plays an essential role in HNO-mediated activation of SERCA.

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Cysteine 674 modulates HNO-stimulated SERCA activation. A, AS decreases SERCA BIAM labeling in myocytes expressing wild-type SERCA (WT). In contrast, in myocytes expressing the C674S SERCA mutant, BIAM labeling is decreased as compared to wild type but is not decreased further by addition of AS (†P<0.01 vs control vehicle; n=3). B, Representative Western blot showing effect of C674S mutant on BIAM labeling. C, AS does not increase SERCA activity in myocytes overexpressing the C674S SERCA mutant (*P<0.05 vs vehicle control; †P<0.05 vs AS in wild type; n=3). Data in A were normalized to the mean of the wild-type control value.

Mechanism of Oxidative Modification

It remains to be determined how HNO causes S-glutathiolation of SERCA. It is possible that HNO leads to generation of NO and/or peroxynitrite. We previously found that peroxynitrite formed from NO can cause S-glutathiolation of SERCA in vascular smooth muscle cells7 and that this effect can be prevented by the peroxynitrite scavenger uric acid.7 Likewise, in ARVMs, we found that peroxynitrite decreases SERCA BIAM labeling and that this decrease is prevented by uric acid (100 ?mol/L; data not shown). However, uric acid had no effect on the decrease in SERCA BIAM labeling or SERCA activation caused by AS (supplemental Figure IV). This finding suggests that peroxynitrite does not mediate HNO-stimulated S-glutathiolation of SERCA. Although further studies will be required to determine the chemical mechanism, our data are consistent with a direct effect of HNO.15 In this regard, it has been proposed that HNO can mediate S-glutathiolation via the formation of a protein thiol N-hydroxysulfenamide intermediate followed by a reaction with GSH.15 Alternatively, HNO might cause GSH depletion, resulting in an oxidative environment that promotes protein S-glutathiolation.16

Role of Phospholamban

Recently, Froehlich et al17 showed that SERCA was not activated by HNO in the absence of phospholamban or with mutation of critical phospholamban cysteines, thus implicating oxidative cysteine modifications of phospholamban. Thus, the regulation of SERCA by HNO may involve oxidative modifications of both SERCA and phospholamban.17 For example, SERCA activation via oxidative modification of cysteine 674 may require and/or synergize with a conformational effect mediated via oxidative thiol modification of phospholamban.

Acknowledgments

Sources of Funding

Supported by NIH grants HL-061639 and HL-064750 (to W.S.C.); NIH grant HL31607 (to R.A.C.); and the National Heart, Lung, and Blood Institute-sponsored Boston University Cardiovascular Proteomics Center (contract no. N01-HV-28178 to R.A.C. and W.S.C.). S.L. was supported by La Fondation pour la Recherche Médicale grant SPE20051105207.

Disclosures

None.

Footnotes

  • Original received December 19, 2008; revision received February 19, 2009; accepted February 23, 2009.

References

  1. ↵
    Tocchetti CG, Wang W, Froehlich JP, Huke S, Aon MA, Wilson GM, Di BG, O'Rourke B, Gao WD, Wink DA, Toscano JP, Zaccolo M, Bers DM, Valdivia HH, Cheng H, Kass DA, Paolocci N. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ Res. 2007; 100: 96–104.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci USA. 2001; 98: 10463–10468.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Katori T, Donzelli S, Tocchetti CG, Miranda KM, Cormaci G, Thomas DD, Ketner EA, Lee MJ, Mancardi D, Wink DA, Kass DA, Paolocci N. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. Free Radic Biol Med. 2006; 41: 1606–1618.
    OpenUrlCrossRefPubMed
  4. ↵
    Miranda KM, Paolocci N, Katori T, Thomas DD, Ford E, Bartberger MD, Espey MG, Kass DA, Feelisch M, Fukuto JM, Wink DA. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc Natl Acad Sci USA. 2003; 100: 9196–9201.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Favaloro JL, Kemp-Harper BK. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc Res. 2007; 73: 587–596.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Irvine JC, Favaloro JL, Kemp-Harper BK. NO-activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension. 2003; 41: 1301–1307.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med. 2004; 10: 1200–1207.
    OpenUrlCrossRefPubMed
  8. ↵
    Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation. 1998; 98: 1329–1334.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Ying J, Clavreul N, Sethuraman M, Adachi T, Cohen RA. Thiol oxidation in signaling and response to stress: detection and quantification of physiological and pathophysiological thiol modifications. Free Radic Biol Med. 2007; 43: 1099–1108.
    OpenUrlCrossRefPubMed
  10. ↵
    Bishop JE, Squier TC, Bigelow DJ, Inesi G. (Iodoacetamido)fluorescein labels a pair of proximal cysteines on the Ca2+-ATPase of sarcoplasmic reticulum. Biochemistry. 1988; 27: 5233–5240.
    OpenUrlCrossRefPubMed
  11. ↵
    Ying J, Tong X, Pimentel DR, Weisbrod RM, Trucillo MP, Adachi T, Cohen RA. Cysteine-674 of the sarco/endoplasmic reticulum calcium ATPase is required for the inhibition of cell migration by nitric oxide. Arterioscler Thromb Vasc Biol. 2007; 27: 783–790.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Pimentel DR, Adachi T, Ido Y, Heibeck T, Jiang B, Lee Y, Melendez JA, Cohen RA, Colucci WS. Strain-stimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol. 2006; 41: 613–622.
    OpenUrlCrossRefPubMed
  13. ↵
    Clavreul N, Bachschmid MM, Hou X, Shi C, Idrizovic A, Ido Y, Pimentel D, Cohen RA. S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol. 2006; 26: 2454–2461.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Viner RI, Williams TD, Schoneich C. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry. 1999; 38: 12408–12415.
    OpenUrlCrossRefPubMed
  15. ↵
    Paolocci N, Jackson MI, Lopez BE, Miranda K, Tocchetti CG, Wink DA, Hobbs AJ, Fukuto JM. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO. Pharmacol Ther. 2007; 113: 442–458.
    OpenUrlCrossRefPubMed
  16. ↵
    Lopez BE, Rodriguez CE, Pribadi M, Cook NM, Shinyashiki M, Fukuto JM. Inhibition of yeast glycolysis by nitroxyl (HNO): mechanism of HNO toxicity and implications to HNO biology. Arch Biochem Biophys. 2005; 442: 140–148.
    OpenUrlCrossRefPubMed
  17. ↵
    Froehlich JP, Mahaney JE, Keceli G, Pavlos CM, Goldstein R, Redwood AJ, Sumbilla C, Lee DI, Tocchetti CG, Kass DA, Paolocci N, Toscano JP. Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl (dagger). Biochemistry. 2008; 47: 13150–13152.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
March 27, 2009, Volume 104, Issue 6
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674
    Steve Lancel, Jingmei Zhang, Alicia Evangelista, Mario P. Trucillo, XiaoYong Tong, Deborah A. Siwik, Richard A. Cohen and Wilson S. Colucci
    Circulation Research. 2009;104:720-723, originally published March 26, 2009
    https://doi.org/10.1161/CIRCRESAHA.108.188441

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Nitroxyl Activates SERCA in Cardiac Myocytes via Glutathiolation of Cysteine 674
    Steve Lancel, Jingmei Zhang, Alicia Evangelista, Mario P. Trucillo, XiaoYong Tong, Deborah A. Siwik, Richard A. Cohen and Wilson S. Colucci
    Circulation Research. 2009;104:720-723, originally published March 26, 2009
    https://doi.org/10.1161/CIRCRESAHA.108.188441
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Contractile Function
    • Oxidant Stress
    • Calcium Cycling/Excitation-Contraction Coupling

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured